A Study of QLF3108 in Participants With Advanced Solid Tumor

Clinical trial NCT06019013 · UNKNOWN

Trial details

NCT number: NCT06019013
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2023-08-16
Primary completion: 2025-12-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.